These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 8441174

  • 61. The urokinase-type plasminogen activator system and inflammatory joint diseases.
    Del Rosso M, Fibbi G, Matucci Cerinic M.
    Clin Exp Rheumatol; 1999; 17(4):485-98. PubMed ID: 10464565
    [Abstract] [Full Text] [Related]

  • 62. Serum and synovial fluid osteocalcin (bone gla protein) levels in joint disease.
    Campion GV, Delmas PD, Dieppe PA.
    Br J Rheumatol; 1989 Oct; 28(5):393-8. PubMed ID: 2790398
    [Abstract] [Full Text] [Related]

  • 63. Cytidine deaminase and lactoferrin in inflammatory synovial fluids. Indicators of local polymorphonuclear cell function?
    Geborek P, Månsson B, Hellmer G, Saxne T.
    Br J Rheumatol; 1992 Apr; 31(4):235-40. PubMed ID: 1555038
    [Abstract] [Full Text] [Related]

  • 64. Interrelationships between interleukin (IL)-1, IL-6 and IL-8 in synovial fluid of various arthropathies.
    Bertazzolo N, Punzi L, Stefani MP, Cesaro G, Pianon M, Finco B, Todesco S.
    Agents Actions; 1994 Mar; 41(1-2):90-2. PubMed ID: 8079829
    [Abstract] [Full Text] [Related]

  • 65. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis.
    Ronday HK, Smits HH, Quax PH, van der Pluijm G, Löwik CW, Breedveld FC, Verheijen JH.
    Br J Rheumatol; 1997 Jan; 36(1):9-15. PubMed ID: 9117184
    [Abstract] [Full Text] [Related]

  • 66. Acute inflammatory intestinal vascular lesions and in situ abnormalities of the plasminogen activation system in Crohn's disease.
    Desreumaux P, Huet G, Zerimech F, Gambiez L, Balduyck M, Baron P, Degand P, Cortot A, Colombel JF, Janin A.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1113-9. PubMed ID: 10524640
    [Abstract] [Full Text] [Related]

  • 67. Synovial fluid concentrations of interleukin-1 beta and proteoglycans are inversely related.
    Saxne T, Di Giovine FS, Heinegård D, Duff GW, Wollheim FA.
    J Autoimmun; 1988 Aug; 1(4):373-80. PubMed ID: 3266994
    [Abstract] [Full Text] [Related]

  • 68. Plasminogen activators and plasminogen activator inhibitor in malignant and non-malignant ascitic fluid.
    Huber K, Wojta J, Kirchheimer JC, Ermler D, Binder BR.
    Eur J Clin Invest; 1988 Dec; 18(6):595-9. PubMed ID: 2852112
    [Abstract] [Full Text] [Related]

  • 69. Substance P and arthritis: analysis of plasma and synovial fluid levels.
    Marshall KW, Chiu B, Inman RD.
    Arthritis Rheum; 1990 Jan; 33(1):87-90. PubMed ID: 1689161
    [Abstract] [Full Text] [Related]

  • 70. Analysis of cartilage-derived retinoic-acid-sensitive protein (CD-RAP) in synovial fluid from patients with osteoarthritis and rheumatoid arthritis.
    Saito S, Kondo S, Mishima S, Ishiguro N, Hasegawa Y, Sandell LJ, Iwata H.
    J Bone Joint Surg Br; 2002 Sep; 84(7):1066-9. PubMed ID: 12358374
    [Abstract] [Full Text] [Related]

  • 71. Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions.
    Saxne T, Heinegård D.
    Arthritis Rheum; 1992 Apr; 35(4):385-90. PubMed ID: 1373620
    [Abstract] [Full Text] [Related]

  • 72. Elevation of synovial plasminogen activator activity after injection of interleukin-1 alpha into rabbit knee joint.
    Ganu VS, Goldberg RL, Blancuzzi VJ, Wilson DE, Doughty J, Melton R, O'Byrne E.
    Agents Actions; 1991 Sep; 34(1-2):226-8. PubMed ID: 1793035
    [Abstract] [Full Text] [Related]

  • 73. Plasminogen activators and tiaprofenic acid in inflammation. A preliminary study.
    Fibbi G, Serni U, Pucci M, Caldini R, Magnelli L, Del Rosso M.
    Drugs; 1988 Sep; 35 Suppl 1():9-14. PubMed ID: 3129275
    [Abstract] [Full Text] [Related]

  • 74. Breed and seasonal variation of plasminogen activator activity and plasminogen activator inhibition in spermatozoa and seminal plasma of the ram in correlation with testosterone in the blood.
    Rekkas C, Kokolis N, Smokovitis A.
    Andrologia; 1993 Sep; 25(2):101-9. PubMed ID: 8465994
    [Abstract] [Full Text] [Related]

  • 75. Expression of plasminogen activator and plasminogen activator inhibitor by rat mesothelioma induced by asbestos.
    Lenz SP, Green FH, Murphy PG, Lee M, Hart DA.
    Cancer Lett; 1993 Feb; 68(2-3):119-27. PubMed ID: 8443784
    [Abstract] [Full Text] [Related]

  • 76. Measurement of sulphated glycosaminoglycans and proteoglycan fragments in arthritic synovial fluid.
    Carroll G.
    Ann Rheum Dis; 1989 Jan; 48(1):17-24. PubMed ID: 2923503
    [Abstract] [Full Text] [Related]

  • 77. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
    Saxne T, Heinegård D, Wollheim FA, Pettersson H.
    Lancet; 1985 Jul 20; 2(8447):127-8. PubMed ID: 2862321
    [Abstract] [Full Text] [Related]

  • 78. Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts.
    Pelletier JP, Mineau F, Fernandes J, Kiansa K, Ranger P, Martel-Pelletier J.
    Clin Exp Rheumatol; 1997 Jul 20; 15(4):393-8. PubMed ID: 9272300
    [Abstract] [Full Text] [Related]

  • 79. Plasminogen activators and plasminogen activator inhibitors in human colorectal carcinoma tissues are not expressed by the tumour cells.
    Koretz K, Möller P, Schwartz-Albiez R.
    Eur J Cancer; 1993 Jul 20; 29A(8):1184-9. PubMed ID: 8518031
    [Abstract] [Full Text] [Related]

  • 80. Influence of delivery on plasminogen activator inhibitor activity.
    Koelbl H, Kirchheimer J, Tatra G.
    J Perinat Med; 1989 Jul 20; 17(2):107-11. PubMed ID: 2681664
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.